[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-366804-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-366804-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","molecular-characterization-of-breast-cancer-and-multiple-primary-malignancies-the-latest-application-using-unmarked-quantitative-proteomics","Molecular characterization of breast cancer and multiple primary malignancies - the latest application using unmarked quantitative proteomics","","Breast cancer remains the most prevalent malignancy among women, and concurrent presentation of breast and lung cancer creates major challenges in clinical diagnosis and treatment. Comprehensive multi-omics analyses for multiple primary malignancies are limited, motivating an integrated strategy. This study combines unmarked quantitative proteomics with radiomics, using patients with single primary breast cancer and patients with multiple primary tumors (breast and lung). Proteomics identifies four molecular signature types, while immune subtyping defines three immune landscapes. Radiomics shows strong correlations between molecular/immune subtypes and imaging phenotypes, with high imaging information scores reflecting tumor heterogeneity and reduced immune infiltration. Findings provide new insights into the molecular pathogenesis of multiple primary malignancies, particularly breast and lung cancer.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/molecular-characterization-of-breast-cancer-and-multiple-primary-malignancies-the-latest-application-using-unmarked-quantitative-proteomics/366804/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/molecular-characterization-of-breast-cancer-and-multiple-primary-malignancies-the-latest-application-using-unmarked-quantitative-proteomics/366804.png","ImageObject",300,407,{"name":42,"@type":43},"awa","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-29","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",8,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What clinical problem does the study address?","Question",{"text":63,"@type":64},"It addresses the difficulty of diagnosing and treating patients who have both breast cancer and lung cancer, where such cases are often misclassified as lung metastasis rather than multiple primary malignancies.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"What data types are integrated in the analysis?",{"text":68,"@type":64},"The study integrates quantitative proteomics with radiomics information derived from imaging, comparing patients with single primary breast cancer and those with multiple primary tumors (breast and lung).",{"name":70,"@type":61,"acceptedAnswer":71},"What major molecular and immune findings are reported?",{"text":72,"@type":64},"Proteomics reveals four distinct molecular signatures (Types I–IV), and immune subtyping identifies three distinct immune landscapes (Types I–III), with different pathway enrichments across single-breast, multiple-breast, and multiple-lung cases.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},366804,1790217499,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":55,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},3985747858093,"https://ap-avatar.wpscdn.com/davatar_3d24733baf745e90a7e4bdd5f77d97b2","Molecular characterization of breast cancer and multiple primary malignancies: the latest application using unmarked quantitative proteomics  \nPing Wang, MDa,b, Shuang Liang, MDa,d, Huiting Zhang, MDa,e, Xiaolong Yang, MSa , Yingjie Li, MSa ,  \nKaige Chen, MSa , Jiayang Wang, MSa, Jiming Shang, MSf, Zhaoyu Qin, MDf, Wenzhong Du, MDc, Wei Meng, MDa ,*  \nBackground: Breast cancer remains the most prevalent malignancy among women, and patients presenting with both breast and lung cancer pose significant challenges in clinical diagnosis and treatment. Currently, comprehensive multi-omics analyses for such multiple malignancies are lacking.  \nMethods: An integrated multi-omics analysis was performed, incorporating quantitative proteomics and radiomics data from patients with single primary breast cancer as well as those with multiple primary tumors (breast and lung cancer) .  \nResults: Quantitative proteomics analysis revealed four distinct molecular signatures (Types I–IV) . Patients with single breast cancer exhibited driving pathways primarily linked to cell proliferation (e.g. , HER2), whereas those with multiple breast cancers showed enrichment in ER-related and proliferative pathways. In contrast, patients with multiple lung cancers displayed pathways associated with immune response and immune escape. Additionally, immune subtyping identified three distinct immune landscapes (Types I–III) . Radiomic analysis demonstrated strong correlations between these molecular/immune subtypes and imaging findings. Patients with high imaging information scores exhibited pronounced tumor heterogeneity and reduced immune infiltration.  \nConclusions: This study provides new insights into the molecular pathogenesis of multiple primary malignancies, particularly breast and lung cancer.  \nKeywords: breast cancer, lung cancer, multiple primary malignancies, quantitative proteomics, radiomics  \nIntroduction  \nBreast cancer remains one of the most clinically significant and life-threatening gynecological malignancies, posing a persistent threat to women’s health[1-3] . Current classification systems primarily rely on HER2 and estrogen receptor status[4,5]; however, the disease’s pronounced heterogeneity and diverse functional phenotypes contribute to substantial variations in histomorphology, proteomic profiles, and genomic landscapes[6,7] . This biological complexity complicates pathological classification  \naDepartment of Radiology, Harbin Medical University, Harbin Medical University Cancer Hospital, 150 Haping Road, Harbin, Heilongjiang, China, bDepartment of Radiology, Beijing Jishuitan Hospital, Capital Medical University, Beijing, China, cDepartment of Neurosurgery, The First Affiliated Hospital of Harbin Medical University, 23 Youzheng Street, Nangang District, Harbin, Heilongjiang Province, China, dDepartment of Radiology, The Second Affiliated Hospital of Mudanjiang Medical University, Mudanjiang City, Heilongjiang Province, China, eDepartment of Ultrasound, First Affiliated Hospital of Harbin Medical University, Harbin, China6Department of Radiology, Beidahuang Industry Group General Hospital, Harbin, Heilongjiang Province, China and fState Key Laboratory of Genetic Engineering, Institutes of Biomedical Sciences, School of Life Sciences, Human  \nPhenome Institute, Fudan University, Shanghai, China Wenzhong Du and Wei Meng are co-senior authors.  \nSponsorships or competing interests that may be relevant to content are disclosed at the end of this article.  \n*Corresponding author. Address: Department of Radiology, Harbin Medical University, Harbin Medical University Cancer Hospital, 150 Haping Road, Harbin, Heilongjiang 150081, China. Tel.: +86 010 69159590.  \n[E-mail: articlemengwei@163.com](E-mail: articlemengwei@163.com) (W. Meng).  \nCopyright © 2025 The Author(s). Published by Wolters Kluwer Health, Inc. This is an open access article distributed under the terms of the Creative Commons  \nand underscores the need for more precise and in","cbCaieT15pPGzSP3","https://ap.wps.com/l/cbCaieT15pPGzSP3","pdf",5342657,15,"English","# Background\n# Methods\n# Results\n## Molecular signatures and immune landscapes\n## Radiomic correlations and imaging features\n# Conclusions\n# Keywords","[{\"question\":\"What clinical problem does the study address?\",\"answer\":\"It addresses the difficulty of diagnosing and treating patients who have both breast cancer and lung cancer, where such cases are often misclassified as lung metastasis rather than multiple primary malignancies.\"},{\"question\":\"What data types are integrated in the analysis?\",\"answer\":\"The study integrates quantitative proteomics with radiomics information derived from imaging, comparing patients with single primary breast cancer and those with multiple primary tumors (breast and lung).\"},{\"question\":\"What major molecular and immune findings are reported?\",\"answer\":\"Proteomics reveals four distinct molecular signatures (Types I–IV), and immune subtyping identifies three distinct immune landscapes (Types I–III), with different pathway enrichments across single-breast, multiple-breast, and multiple-lung cases.\"}]","Molecular characterization of breast cancer and multiple primary malignancies - the latest application using unmarked quantitative proteomics | PDF",1790167584,38,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/cea7752c445d2b4b87954aea73702f48.webp",983,1310,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4cd69ef34c31d98ba5ef545d10cc2e8e.webp",982,1309,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3a1516a0d8ca909a976b2aabda00ae7c.webp",981,1308,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/09dd422f2a8bc8e23aa9917b31810904.webp",980,1306]